About US
Contact us
-
Roche decides to fold up its tent when Illumina offer expiresRoche ($RHHBY) said it wouldn't extend its $51-per-share bid for Illumina, after voting tallies indicated that shareholders backed the gene-sequencing company's incumbent board candidates, rather than2012/4/19
-
WSJ: Pfizer poised to sell nutrition biz to Nestlé for $9B-plusIt looks as if Nestlé has prevailed in the bidding for Pfizer's nutrition unit. Sources tell The Wall Street Journal that the Swiss food company is close to snapping up the business for at least $92012/4/19
-
Chinese regulators freeze sales of drugs with toxic capsulesAnother scandal is roiling China's burgeoning pharma industry. The country's drug watchdog has banned the sale of 13 drugs that include traditional Chinese meds and antibiotics that are made with c2012/4/18
-
Supreme Court zeroes in on pharma reps' OT claimsWill pharma reps' crusade for overtime pay survive the U.S. Supreme Court? Hearing arguments in a key case yesterday, some of the justices seemed skeptical of the very idea. And at least one was cl2012/4/18
-
Justice, J&J duel over Gorsky's contribution to kickback caseAlex Gorsky's name has surfaced in the U.S. government's Risperdal marketing lawsuit just weeks before he is supposed to step into the role of CEO at the healthcare giant Johnson & Johnson ($JNJ).2012/4/17
-
S. Africa ratchets up protection for domestic drugmakersWarning to pharma companies aiming to sell key drugs in South Africa: Only domestic drugmakers need apply. The government is putting together a list of 70-plus medications that will have to be proc2012/4/17
-
Bayer to pay $110 million to get out from under 500 Yaz lawsuitsThree months of negotiations have apparently resulted in Bayer ($BAYN) deciding that claims against itsYasminline of birth control are worth about $220,000 each. Citing sources,Bloombergreports, the2012/4/16
-
Novartis reports patient taking Gilenya developed rare brain diseaseExpectations for the blockbuster status of Gilenya dimmed today when developer Novartis ($NVS) disclosed that a patient taking the multiple-sclerosis drug has developed a rare brain disease. The c2012/4/16
-
FDA to require prescriptions for farm antibioticsThe FDA will require farmers to get prescriptions for livestock antibiotics under new rules designed to curb development of antibiotic-resistant pathogens. The agency says antibiotics should only be g2012/4/13
-
Roche jeers at Illumina's boasts as proxy fight escalatesAnthropologists could gather plenty of material during a hostile bid. The competing press releases, the public correspondence, the CEO statements--a PhD candidate could spin all that into a respectabl2012/4/13